Biofarm S.A. (BVB: BIO)

Market Cap	760.70M
Revenue (ttm)	259.28M
Net Income (ttm)	68.89M
Shares Out	985.37M
EPS (ttm)	0.06
PE Ratio	12.10
Forward PE	n/a
Dividend	0.03 (3.98%)
Ex-Dividend Date	Aug 20, 2024

Volume	26,963
Open	0.776
Previous Close	0.776
Day's Range	0.770 - 0.778
52-Week Range	0.722 - 0.910
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Biofarm

Biofarm S.A. engages in the manufacture and sale of medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 399
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2023, Biofarm's revenue was 280.29 million, an increase of 1.19% compared to the previous year's 276.98 million. Earnings were 77.01 million, an increase of 8.60%.